Digital Biomarkers Market Analysis

  • Report ID: 3217
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Digital Biomarkers Market Segmentation:

Application Segment Analysis

The neurological segment is poised to dominate the digital biomarkers market over the assessed timeline with 32% of the revenue share. The leadership is primarily driven by the enlarging patient pool of Alzheimer's and Parkinson's disease. The presence of several clinical studies demonstrating the therapeutic and economic advantages of AI-powered tools in detecting and treating neurological diseases is escalating adoption in this category. According to Parkinson’s Foundation, more than 1.1 million people in the U.S. are suffering from Parkinson’s disease. These factors are augmenting the segment growth during the coming period.

Type Segment Analysis

The wearable segment is predicted to garner the maximum share, mainly because wearables are considered to be the most comfortable choice for the consumer as a continuous monitoring tool. These devices can capture real-time physiological data in very natural settings. The subsegment growth can also be attributed to the rising consumerism of healthcare. People are now actively seeking tools that track health with the use of devices from popular brands such as Apple, Fitbit, etc.  Also, continuous advancements in sensors such as SpO2 and ECG are giving more accurate insights and are highly preferred by people.

End-user Segment Analysis

Hospitals and clinics mainly hold the largest market share, and the leadership stems from their primary position in delivering patient care. Hospitals and clinics are relying on wearable devices and AI-enabled analytics to get the behavioral data of the patients. The burgeoning burden of chronic diseases and demand for minimally invasive monitoring are further propelling the segment growth. Healthcare providers are the early adopters of remote patient monitoring for giving post-discharge care. Hospitals are integrating electronic health records from the digital biomarkers, which is reinforcing the largest share in the market.

Our in-depth analysis of the global market includes the following segments:

Segment

Subsegments

Type

  • Wearables
    • Wrist
    • Patch
    • Implantable
  • Mobile applications
  • Sensors
    • ECG patches
    • SpO2
    • Accelerometers
  • Implantable
  • Continuous glucose monitors
  • Software/AI platforms
  • Cloud/analytics services

Clinical Practice

  • Monitoring digital biomarkers
  • Diagnostic digital biomarkers
  • Predictive & prognostic biomarkers
  • Therapeutic-response biomarkers
  • Safety/validation biomarkers

Application

  • Cardiovascular & metabolic
  • Neurological
    • Parkinson’s
    • Alzheimer’s
  • Respiratory
    • COPD
    • Asthma
  • Psychiatric/mood disorders
  • Oncology
  • Musculoskeletal
  • Rare diseases
  • General wellness

End user

  • Healthcare providers
  • Pharmaceutical & biotech
  • Payers/insurers
  • Consumers
  • Research institutions/CROs

System Component

  • Hardware devices
    • Biosensors
    • Wearables
  • Middleware
  • Analytics/AI software
  • RPM programs
  • Integration/EHR connectors

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the digital biomarkers market was over USD 5.15 billion.

The market size for the digital biomarkers market is projected to reach USD 36 billion by the end of 2035, expanding at a CAGR of 22% during the forecast period, i.e., between 2026-2035.

The major players in the market are Apple, AliveCor, Fitbit (Google subsidiary), Verily Life Sciences, Biogen, Roche, Siemens Healthineers, Philips, Bayer, Huma, ResApp Health, Samsung Electronics, LG Electronics, Tata Consultancy Services and others.

In terms of type, the neurological segment is anticipated to garner the largest market share of 32% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 42.1% by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos